MLNCX
Price
$26.17
Change
-$0.17 (-0.65%)
Updated
Jun 2 closing price
Net Assets
423.72M
RNPCX
Price
$73.05
Change
+$0.08 (+0.11%)
Updated
Jun 2 closing price
Net Assets
164.3B
Interact to see
Advertisement

MLNCX vs RNPCX

Header iconMLNCX vs RNPCX Comparison
Open Charts MLNCX vs RNPCXBanner chart's image
MLNCX vs RNPCX Comparison Chart in %
View a ticker or compare two or three
VS
MLNCX vs. RNPCX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLNCX is a Buy and RNPCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPCX has more cash in the bank: 164B vs. MLNCX (424M). RNPCX pays higher dividends than MLNCX: RNPCX (0.70) vs MLNCX (0.00). MLNCX was incepted earlier than RNPCX: MLNCX (10 years) vs RNPCX (24 years). MLNCX (2.08) is less costly to investors than RNPCX (1.05). MLNCX is a more actively managed with annual turnover of: 51.00 vs. RNPCX (23.00). RNPCX has a lower initial minimum investment than MLNCX: RNPCX (250) vs MLNCX (1000). RNPCX annual gain was more profitable for investors over the last year : 13.40 vs. MLNCX (11.09). MLNCX return over 5 years is better than : 43.31 vs. RNPCX (17.30).
MLNCXRNPCXMLNCX / RNPCX
Total Expense Ratio2.081.05198%
Annual Report Gross Expense Ratio2.081.05198%
Fund Existence10 years24 years-
Gain YTD4.4007.10462%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets424M164B0%
Annual Yield % from dividends0.000.70-
Returns for 1 year11.0913.4083%
Returns for 3 years73.1842.43172%
Returns for 5 years43.3117.30250%
Returns for 10 years162.66110.50147%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAIN16.010.11
+0.69%
Gladstone Investment Corp
EXFY1.17N/A
+0.43%
Expensify
BEKE17.230.05
+0.29%
KE Holdings
MBIO0.76-0.01
-0.86%
Mustang Bio Inc
HAE66.37-0.85
-1.26%
Haemonetics Corp